Literature DB >> 15569478

Correlation of HDEFB1 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population.

Rui-Cheng Hu1, Yong-Jian Xu, Zhen-Xiang Zhang, Wang Ni, Shi-Xin Chen.   

Abstract

BACKGROUND: Inherited factors are involved in the development of chronic obstructive pulmonary disease (COPD). This study was designed to investigate the relationship between polymorphisms of HDEFB1 668 C/G and 1654G/A loci and susceptibility to COPD in Chinese Han population.
METHODS: After the process of extracting genomic DNA from peripheral blood of COPD smokers and healthy smokers, the loci of genotypes 668C/G and 1654G/A were determined by polymerase chain reaction-restriction fragment length polymorphism analysis and polymerase chain reaction-single strand conformation polymorphism analysis.
RESULTS: With respect to HDEFB1 668 locus, the occurences of CC, CG, GG genotypes were 72.7%, 25.0%, 2.3% in COPD smokers and 53.2%, 38.3%, 8.5% in healthy smokers (P < 0.05, respectively). The allele frequencies of 668 C and 668G were 85.2% and 14.8% in COPD smokers and 72.3% and 27.7% in healthy smokers (P < 0.01, respectively, odds ratio was 2.32 with 95% confidence interval 1.37 to 3.72). As to HDEFB1 1654G/A locus, neither genotype distribution difference nor allele distribution difference was found when comparing COPD smokers with healthy smokers.
CONCLUSION: The polymorphism of HDEFB1 668C/G is associated with susceptibility to COPD in Chinese Han population; furthermore, the 668G allele represents relatively lower susceptibility to COPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569478

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  8 in total

1.  A case of bilateral endophthalmitis and carriage of beta-defensin 1 44CC genotype.

Authors:  James Carter; Amanda J Churchill; Chris Gorman; Richard Haynes
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

Review 2.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 3.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

4.  Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease.

Authors:  Ellen Andresen; Gunar Günther; Jörn Bullwinkel; Christoph Lange; Holger Heine
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

5.  A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans.

Authors:  Jeffrey Tomalka; Sandhya Ganesan; Elaheh Azodi; Krupen Patel; Parth Majmudar; Brian A Hall; Katherine A Fitzgerald; Amy G Hise
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

6.  Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study.

Authors:  Alison M Wallace; Jian-Qing He; Kelly M Burkett; Jian Ruan; John E Connett; Nicholas R Anthonisen; Peter D Paré; Andrew J Sandford
Journal:  Respir Res       Date:  2006-05-15

7.  Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes.

Authors:  Andrea A Kalus; L Page Fredericks; Beth M Hacker; Henrik Dommisch; Richard B Presland; Janet R Kimball; Beverly A Dale
Journal:  BMC Oral Health       Date:  2009-08-27       Impact factor: 2.757

8.  Airway β-Defensin-1 Protein Is Elevated in COPD and Severe Asthma.

Authors:  Katherine J Baines; Thomas K Wright; Jodie L Simpson; Vanessa M McDonald; Lisa G Wood; Kristy S Parsons; Peter A Wark; Peter G Gibson
Journal:  Mediators Inflamm       Date:  2015-10-19       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.